Publications by authors named "Alex Chehrazi-Raffle"

Claim this Profile
A
Assessment of Compliance With ASCO Language of Respect Guidelines in Renal Cell Carcinoma Abstracts.
Nazli Dizman, Ruchi Agarwal, Daniela V Castro, Benjamin Mercier, Xiaochen Li, Alex Chehrazi-Raffle

JCO Oncol Pract· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Darolutamide plus androgen-deprivation therapy in high-risk biochemical recurrence of prostate cancer (ARASTEP).
Alicia K Morgans, Alex Chehrazi-Raffle, Tamim Niazi, Neal D Shore, Ashley E Ross

Future Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility and acceptability of a mindfulness app-based intervention among patients with metastatic renal cell carcinoma: a multinational study.
Cristiane Decat Bergerot, Paulo Gustavo Bergerot, Errol J Philip, Jasnoor Malhotra, Daniela V Castro, Alex Chehrazi-Raffle

Oncologist· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.
Hedyeh Ebrahimi, Nazli Dizman, Luis Meza, Jasnoor Malhotra, Xiaochen Li, Alex Chehrazi-Raffle

Nat Med· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and ethnic differences in perceptions of germline or somatic DNA sequencing among patients with advanced prostate, urothelial, or kidney cancer.
Cristiane Decat Bergerot, Errol J Philip, Jasnoor Malhotra, Paulo Gustavo Bergerot, Daniela V Castro, Alex Chehrazi-Raffle

J Genet Couns· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of Dietary Modification and Supplement Use in Patients with Metastatic Renal Cell Carcinoma Receiving Systemic Therapy.
Hedyeh Ebrahimi, Dena Battle, Nicholas J Salgia, Zeynep B Zengin, Nazli Dizman, Alex Chehrazi-Raffle

Nutrients· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Mutational Burden in Metastatic Castration-Resistant Prostate Cancer and Response to Checkpoint Inhibition.
Peter D Zang, Neal S Chawla, Regina Barragan-Carrillo, Alex Chehrazi-Raffle, Abhishek Tripathi

JAMA Oncol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of eligibility criteria in renal cell carcinoma trials evaluating systemic therapy.
Daniela V Castro, Sweta R Prajapati, Matthew I Feng, Elyse H Chan, Kyle O Lee, Alex Chehrazi-Raffle

BJU Int· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Perception of Cure Among Patients With Genitourinary Cancers Initiating Immune Checkpoint Inhibitors: A Longitudinal Study.
Cristiane Decat Bergerot, Errol J Philip, Ameish Govindarajan, Daniela Castro, Jasnoor Malhotra, Alex Chehrazi-Raffle

Clin Genitourin Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Boosting CAR T cells with anti-tumor mRNA vaccines.
Alex Chehrazi-Raffle, Lihua E Budde, Sumanta K Pal

Nat Med· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unique Spectrum of Activating BRAF Alterations in Prostate Cancer.
Alex Chehrazi-Raffle, Hanna Tukachinsky, Eamon Toye, Smruthy Sivakumar, Alexa B Schrock

Clin Cancer Res· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Time-of-Day of Immune Checkpoint Blockade Administration and Outcomes in Metastatic Renal Cell Carcinoma.
Nazli Dizman, Ameish Govindarajan, Zeynep B Zengin, Luis Meza, Nishita Tripathi, Alex Chehrazi-Raffle

Clin Genitourin Cancer· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Twelve-Month Follow-up of the Immune Response After COVID-19 Vaccination in Patients with Genitourinary Cancers: A Prospective Cohort Analysis.
Luis Meza, Zeynep Zengin, Sabrina Salgia, Jasnoor Malhotra, Ewa Karczewska, Alex Chehrazi-Raffle

Oncologist· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and Transcriptomic Predictors of Response from Stereotactic Body Radiation Therapy in Patients with Oligoprogressive Renal Cell Carcinoma.
Zeynep B Zengin, Ameish Govindarajan, Nicholas Salgia, Nicolas Sayegh, Nishita Tripathi, Alex Chehrazi-Raffle

Eur Urol Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of papillary and clear cell renal cell carcinoma through imaging mass cytometry reveals distinct immunologic profiles.
Ameish Govindarajan, Nicholas J Salgia, Haiqing Li, Daniela V Castro, Tamara Mirzapoiazova, Alex Chehrazi-Raffle

Front Immunol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions of COVID-19 Vaccination in Patients with Genitourinary Cancers: A Survey Study.
Daniela V Castro, Zeynep B Zengin, Jasnoor Malhotra, Cristiane D Bergerot, Luis Meza, Alex Chehrazi-Raffle

Cancer Invest· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial.
Nazli Dizman, Luis Meza, Paulo Bergerot, Marice Alcantara, Tanya Dorff, Alex Chehrazi-Raffle

Nat Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma.
Zeynep B Zengin, Alex Chehrazi-Raffle, Nicholas J Salgia, Ramya Muddasani, Sana Ali

Urol Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis